BIOS

BioPlus Acquisition Corp. [BIOS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

BIOS Stock Summary

In the News

BIOS Financial details

Company Rating
-
Market Cap
209.07M
Income
11.85M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
3.63
Forward P/E
-
PEG
-0.03
P/S
-
P/B
0.35
P/C
-
P/FCF
-129.65
Quick Ratio
69.94
Current Ratio
0.1
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.28
EPS next Y
-
EPS next Q
-
EPS this Y
-138.74%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-70.59%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
9%
ROE
6%
ROC
-0.02%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
10.12-11.68
52W High
-
52W Low
-
RSI
50
Rel Volume
0.16
Avg Volume
35.93K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

Something similar

Top by Market Cap
APC.DE
GOOG
VOO
AAPL
AVGO
Same Sector
AINC
JDST
278530.KS
DWS.DE
ACTV
Check Those
IMIDX
1216.HK
CPSR
EFGD.IL
000868.SZ
Similar Market Cap
FLTB
MULG
MNSBP
TDV
OXSQL

Company Profile

Financial Services Shell Companies
  • Volume Average 35.93K
  • Market Capitalization 209.07M
  • CEO Mr. R. Ross Haghighat
  • Headquarters New York,NY,US
  • IPO Date 2022-01-28
  • Website https://bioplusspac.com

BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.